Amrita Jain

Before joining LongeVC, Amrita worked at Fusix Biotech, a pre-clinical-stage biotechnology company developing a next-generation oncolytic virus platform to treat patients across multiple tumour types. She was also a Business Development Manager for cancer immunotherapy company Immatics Biotechnologies and an Investment Analyst at venture capital fund Life Science Partners ( LSP).

Amrita holds a Master's degree in Genome Sciences/Genomics from Madurai Kamaraj University and a PhD in Biochemistry and Molecular Biology from the University of Utrecht.